Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong.

Slides:



Advertisements
Similar presentations
Surveillance in a Pandemic: Situational Awareness
Advertisements

H3N2 variant influenza A Maine, 2011 Sara Robinson, MPH Epidemiologist Maine Center for Disease Control and Prevention.
Swine Influenza April 30, 2009 Bill Mason, MD Jill Hoffman, MD Dawn England, MPH.
Laboratory Diagnostics and Specimen Collection. Learning Objectives Know the basic components of specimen collection kits for use with suspect avian influenza.
MERS-CoV: Reporting and Laboratory Testing Republic of Lebanon Ministry of Public Health Epidemiological Surveillance Program May 2014.
A Word about… Rapid Influenza Diagnostic Testing (RIDT) Kelly L. Moore, MD, MPH Director, TN Immunization Program TDH Regional Epidemiology Meeting Montgomery.
Screening of Human and Animal Sera from Egypt and Hong Kong Perera et al. Euro Surveill. 2013;18(36):pii=20574 Sampled 1343 Human, 625 animals.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
EPIDEMIOLOGY AND SURVEILLANCE Southwest Florida Disaster Healthcare Coalition June 13, 2014 Jennifer Roth, MSPH Director of Epidemiology Florida Department.
Lisa Grohskopf, MD, MPH Medical Officer Influenza Division Centers for Disease Control and Prevention U.S. Influenza Surveillance National Center for Immunization.
Outbreak Investigation: The First 48 Rachel Radcliffe, DVM, MPH Career Epidemiology Field Officer Division of Infectious Disease Epidemiology West Virginia.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
SARS The Toronto Outbreak April 20, SARS in Toronto I: Index Case February 23 – A 78 year old woman arrives back in Toronto from trip to Hong Kong.
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.
Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.
Human Infection with Avian Influenza A(H7N9) Virus: Situation and Response, China Zijian FENG Center for Public Health Emergency Center Chinese Center.
Infectious Disease Epidemiology Section Office of Public Health Louisiana Department of Health and Hospitals
Novel Coronavirus and H7N9 Influenza Infections Situation update May 2013 Craig Roberts, PA-C, MS ACHA Emerging Public Health Threats & Emergency Response.
Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.
1 Detection and Response to Infectious Disease Outbreaks H5N1 as a case-study Daniel S. Miller MD, MPH International Influenza Unit U.S. Department of.
Investigation of Suspected Cases of Human Infection with Avian Influenza A (H5N1) Virus 1.
Centers for Disease Control and Prevention Program title: Developing sustainable surveillance and response for seasonal and avian influenza. Goal: To establish.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
Public Health Issues of Interest Seasonal Influenza Seasonal Norovirus Middle East Respiratory Syndrome Coronavirus Novel Influenza (A/H7N9) David H. Trump,
Outbreak of influenza A (H3N2) in a residence for mentally disabled persons in Ljubljana, Slovenia, 2013 Epidemiology and Public Health Valencia, Spain.
U.S. Influenza Surveillance Keiji Fukuda Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Dr. Zhen XU Branch of Respiratory Disease Prevention and Control Division for Disease Control and Emergency Response Chinese Center for Disease Control.
Influenza and the Nursing Home Population Julie L. Freshwater, PhD MPH Influenza Surveillance Coordinator 1.
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
Danilo Saniatan R.N Charge Nurse RAC-Khurais Clinic.
Influenza Surveillance Danae Bixler, MD, MPH Infectious Disease Epidemiology Program.
Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.
Pandemic Response and current activities in Lao PDR NIC Meeting, Beijing, Aug 2009 Dr Phengta Vongphrachanh Director National centre for Laboratory.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
SARS. What is SARS? Severe Acute Respiratory Syndrome Respiratory illness Asia, North America, and Europe Previously unrecognized coronavirus.
Case Management of Suspect Avian Influenza A (H5N1) Virus Infection in Humans May, 2007.
SEVERE ACUTE RESPIRATORY SYNDROME – UPDATE Anne-Claire de Benoist and Delia Boccia, European Programme for Intervention.
Severe acute respiratory syndrome. SARS. SARS is a communicable viral disease caused by a new strain of coronavirus. The most common symptoms in patient.
THE DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORK IN THE PHILIPPINES (June 2005 – March 2008)‏ Remigio M. Olveda 1, Enrique A. Tayag 2, Analisa N. Bautista.
Plans to Assess the Effectiveness of Seasonal and Pandemic Influenza Vaccines during David Shay MD, MPH (Prevention Assessment and Modeling Team.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
Seoul Metropolitan Government Health & Welfare Headquarters Health Policy Division Kui-Nam Kim.
MERS-CoV (Middle Eastern Respiratory Syndrome) Mike Wade – 16/06/15, updated 23/7/15.
Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.
COMPARISON OF LABORATORY DIAGNOSTIC PROCEDURES FOR DETECTION OF MYCOPLASMA PNEUMONIAE IN COMMUNITY OUTBREAKS KATHLEEN A. THURMAN, NICHOLAS D. WALTER, STEPHANIE.
Understanding Epidemiology Introduction to Epidemiology and Epidemiological Concepts.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
1. Globalization High Mobility of Human Globalization of infectious disease outbreaks Lessons from Pandemic (H1N1) 2009 Concern of next pandemic due to.
The State of Communicable Diseases in Indiana
Outbreak Investigation
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
Point Prevalence Survey in a Long Term Care Facility, 2016
Avian Influenza A (H5N1) “Bird Flu”
Flu Update and Overview of Flu Surveillance in RI
Outbreak Investigations
Utah Zika investigation, July 2016
Believed discrimination occurred because of their:
Establishment of Influenza Surveillance System in Liberia
World Health Organization
Active Surveillance for EHF Cases, Equateur Province, DR Congo (Zaire), November-December 1976
Annual UW Disaster Exercise
Severe Acute Respiratory Syndrome (SARS)
DEPARTMENT OF MEDICINE, UOM
U.S. Influenza Sentinel Provider Surveillance Network
Decision Making During a Novel H1N1 Influenza Epidemic
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
National Immunization Conference
Presentation transcript:

Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong Li, M.D., Huanyu Wu, M.D., Nijuan Xiang, M.D., Enfu Chen, M.P.H., Zhiheng Hong, M.D., and Fenyang Tang, M.D. The New England Journal of Medicine 2014 R4 Seon Hye Kim / Prof. Mi Suk Lee

Background The first identified cases of avian influenza A(H7N9) virus infection in humans occurred in China during February and March and were characterized by rapidly progressive pneumonia, respiratory failure, the ARDS, and fatal outcomes. We analyzed available data from field investigations to characterize the descriptive epidemiology of laboratory-confirmed cases of avian influenza A(H7N9) virus infection in humans that were reported to the Chinese Center for Disease Control and Prevention (Chinese CDC) as of December 1, We summarize the epidemiologic findings of case investigations and follow-up monitoring of close contacts of persons with confirmed cases of H7N9 virus infection who have been identified to date. Investigations are ongoing.

Methods : Case Definitions A confirmed H7N9 case – a patient with influenza like illness(ILI) – a suspected case with respiratory specimens that tested positive for H7N9 virus by any of the following: 1)isolation of H7N9 virus 2)positive results by rRT-PCR assay for H7N9 3)4-fold or greater rise in Ab titer for H7N9 virus based on testing of an acute serum specimen (collected ≤ 7 days after symptom onset) and a convalescent serum specimen (collected at least 2 weeks later).

Methods : Identification of cases Beginning on April 3, 2013, enhanced surveillance was implemented for suspected cases of H7N9 virus infection among persons with mild or moderate illness Each suspected case of H7N9 virus infection was identified, the local CDCs (initial field investigations & respiratory specimens) National Influenza Center of the China CDC in Beijing for H7N9 laboratory testing. The China CDC was involved in field investigations of the first 82 confirmed cases of H7N9 virus infection; local CDCs conducted field investigations of subsequent confirmed cases.

Methods Data collection – collected information on the dates of illness onset, visits to clinical facilities, hospitalization, and clinical outcomes. – all epidemiologic information, including exposure history, timelines of events, and identification of close contacts, was cross-validated – through a review of medical records and interviews with relatives, contacts, and healthcare workers Identification and f/u of close contact – close contacts of patients with confirmed H7N9 virus infection – monitored daily for 7 days for symptoms of illness & collected throat swabs – paired serum samples were obtained for H7N9 serologic testing

Result Epidemiologic Characteristics of Confirmed Cases – From March 25 through December 1, 2013, respiratory specimens from 1372 hospitalized patients with pneumonia of unexplained origin were tested, and 104 patients (7.6%) were confirmed to be infected with the H7N9 virus. – Of 2,130,049 respiratory specimens obtained from outpatients with an influenza-like illness through the sentinel surveillance system for influenza-like illness, 8 (0.0004%) tested positive for the H7N9 virus. – As of December 1, 2013, a total of 139 laboratory-confirmed cases of H7N9 virus infection

Table 1. Comparison of baseline characteristics btw pts with and those w/o anterior chest wall (ACW) pain

Result

Table 1. Epidemiologic Characteristics of 139 Patients with Confirmed H7N9 Virus Infection Study patients

Table 1. Epidemiologic Characteristics of 139 Patients with Confirmed H7N9 Virus Infection Study patients

Table 2. Clinical Characteristics and Medical Care Timelines

Result

Table 2. Stepwise multivariate analysis (the item “diagnosis of ankylosing spondylitis before inclusion in the study” not included in the analysis, because of its relationship with radiological sacroiliitis): significant results.  father  brother  father  daughter

Result Table 2. Stepwise multivariate analysis (the item “diagnosis of ankylosing spondylitis before inclusion in the study” not included in the analysis, because of its relationship with radiological sacroiliitis): significant results.  wife  husband  father  son

Result Close contact – Data were available for 2675 close contacts with confirmed cases – Among the 1953 close contacts (demographic information was available), 1039 (53%) were health care workers, 515 (26%) were family members or relatives, and 399 (20%) were social contacts. – All 2675 contacts had been followed for up for 7 days; among these close contacts, respiratory symptoms developed during the 7-day surveillance period in 28 (1%): throat swabs were collected, but all 28 ill close contacts were negative for the H7N9 virus, as assessed by means of rRT-PCR.

Conclusion A novel avian influenza A(H7N9) virus has caused severe and fatal lower respiratory tract illness in persons in 12 different areas of China. Most confirmed H7N9 cases were epidemiologically unrelated. most case patients were probably exposed to H7N9 virus and infected during visits to live poultry markets, and the decline in cases during may followed the closure of live poultry markets in Shanghai municipality and 9 provinces. However, in 4 family clusters, limited, non-sustained human-to- human transmission of H7N9 virus could not be ruled out and may have occurred. Therefore, enhanced surveillance for H7N9 virus among poultry and people are all critical to informing prevention and control efforts and assessing the pandemic potential of this H7N9 virus.

Thank you for listening